Connor, Clark & Lunn Investment Management (CC&L)
NVLN

Connor, Clark & Lunn Investment Management (CC&L)’s Novelion Therapeutics Inc. Common Shares NVLN Stock Holding History

Connor, Clark & Lunn Investment Management (CC&L)’s Portfolio NVLN Stock Details NVLN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2017
Q3 		– Sell
-11,707
Closed -$108K – 974
2017
Q2 		$108K Sell
11,707
-45,622
-80% -$421K ﹤0.01% 783
2017
Q1 		$615K Sell
57,329
-111,906
-66% -$1.2M ﹤0.01% 589
2016
Q4 		$1.42M Buy
+169,235
New +$1.42M 0.01% 424